DK0585026T3 - Anvendelse af fedtsyrer til forøgelse af calciumabsorption fra tarmen - Google Patents
Anvendelse af fedtsyrer til forøgelse af calciumabsorption fra tarmenInfo
- Publication number
- DK0585026T3 DK0585026T3 DK93306444.6T DK93306444T DK0585026T3 DK 0585026 T3 DK0585026 T3 DK 0585026T3 DK 93306444 T DK93306444 T DK 93306444T DK 0585026 T3 DK0585026 T3 DK 0585026T3
- Authority
- DK
- Denmark
- Prior art keywords
- calcium absorption
- intestine
- fatty acids
- increase calcium
- increase
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 title abstract 2
- 229910052791 calcium Inorganic materials 0.000 title abstract 2
- 239000011575 calcium Substances 0.000 title abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 210000000936 intestine Anatomy 0.000 title 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fertilizers (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929217780A GB9217780D0 (en) | 1992-08-21 | 1992-08-21 | Fatty acid treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0585026T3 true DK0585026T3 (da) | 1998-06-02 |
Family
ID=10720716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93306444.6T DK0585026T3 (da) | 1992-08-21 | 1993-08-16 | Anvendelse af fedtsyrer til forøgelse af calciumabsorption fra tarmen |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5618558A (enExample) |
| EP (1) | EP0585026B1 (enExample) |
| JP (1) | JPH06157303A (enExample) |
| KR (1) | KR940003553A (enExample) |
| CN (1) | CN1049334C (enExample) |
| AT (1) | ATE159856T1 (enExample) |
| AU (1) | AU666747B2 (enExample) |
| CA (1) | CA2104567A1 (enExample) |
| DE (1) | DE69315020T2 (enExample) |
| DK (1) | DK0585026T3 (enExample) |
| ES (1) | ES2110060T3 (enExample) |
| GB (1) | GB9217780D0 (enExample) |
| GR (1) | GR3025898T3 (enExample) |
| HK (1) | HK1000997A1 (enExample) |
| MY (1) | MY109928A (enExample) |
| NO (1) | NO306655B1 (enExample) |
| NZ (1) | NZ248422A (enExample) |
| RU (1) | RU2122409C1 (enExample) |
| SG (1) | SG80536A1 (enExample) |
| TW (1) | TW323230B (enExample) |
| ZA (1) | ZA935976B (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
| GB9403855D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
| EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
| US5804210A (en) * | 1996-08-07 | 1998-09-08 | Wisconsin Alumni Research Foundation | Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein |
| GB9617847D0 (en) | 1996-08-27 | 1996-10-09 | Scotia Holdings Plc | Fatty acid treatment |
| WO1999003456A2 (en) * | 1997-07-16 | 1999-01-28 | Societe Des Produits Nestle S.A. | Method for prophylaxis or treatment of bone density loss |
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
| US6479545B1 (en) * | 1999-09-30 | 2002-11-12 | Drugtech Corporation | Formulation for menopausal women |
| EG22407A (en) * | 2000-02-17 | 2003-01-29 | Iams Company | Method for improving bone modeling and chondrocyte functioning in growing canines |
| EP1854462A1 (en) * | 2001-03-15 | 2007-11-14 | DSMIP Assets B.V. | Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| EP1380293A4 (en) * | 2001-03-30 | 2009-03-18 | Nisshin Oillio Group Ltd | MEANS TO IMPROVE BONE MATERIAL CHANGE |
| US7098352B2 (en) * | 2001-11-16 | 2006-08-29 | Virtus Nutrition Llc | Calcium salt saponification of polyunsaturated oils |
| WO2005063231A2 (en) * | 2003-12-31 | 2005-07-14 | Igennus Limited | Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or esther thereof |
| MXPA06013990A (es) * | 2004-04-30 | 2007-08-14 | Virtus Nutrition Llc | Sintesis de sal de metal monovalente y divalente de acido graso polinsaturado. |
| EP1968402A2 (en) * | 2005-10-07 | 2008-09-17 | Ocean Nutrition Canada Limited | Salts of fatty acids and methods of making and using thereof |
| DE102007022694A1 (de) * | 2007-05-11 | 2008-11-13 | Humana Milchunion Eg | Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme |
| DE102007039310A1 (de) * | 2007-08-13 | 2009-02-19 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Zusammensetzung zur Prophylaxe und Behandlung von Osteoporose |
| US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| EP3187182B1 (en) | 2008-09-02 | 2021-03-03 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| EP2395991B1 (en) * | 2009-02-10 | 2013-05-29 | Amarin Pharmaceuticals Ireland Limited | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia |
| AU2010241571B2 (en) | 2009-04-29 | 2014-06-26 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| CN102413825A (zh) | 2009-04-29 | 2012-04-11 | 阿马里纳股份公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
| GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| WO2010147994A1 (en) | 2009-06-15 | 2010-12-23 | Amarin Pharma, Inc. | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| AU2010298222B2 (en) | 2009-09-23 | 2017-01-05 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| EP3583849A1 (en) * | 2010-03-04 | 2019-12-25 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating and/or preventing cardiovascular disease |
| US8178707B2 (en) | 2010-03-25 | 2012-05-15 | Jost Chemical Company | Co-precipitated salts of fatty acids |
| CN101978949A (zh) * | 2010-11-16 | 2011-02-23 | 王京南 | γ-亚麻酸酯脂肪乳静脉注射液及其制造方法 |
| NZ778131A (en) | 2010-11-29 | 2023-03-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| EP2775837A4 (en) | 2011-11-07 | 2015-10-28 | Amarin Pharmaceuticals Ie Ltd | METHODS OF TREATING HYPERTRIGLYCERIDEMIA |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| AU2013207368A1 (en) | 2012-01-06 | 2014-07-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity (hs-CRP) in a subject |
| LT3363433T (lt) | 2012-06-29 | 2021-02-25 | Amarin Pharmaceuticals Ireland Limited | Širdies ir kraujagyslių sistemos sutrikimų rizikos sumažinimo būdas subjektui, gydomam statinais, panaudojant eikozapentaeno rūgšties etilo esterį |
| WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
| US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
| US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
| US8728546B1 (en) | 2013-03-15 | 2014-05-20 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer, cardiovascular diseases and inflammation |
| US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
| US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
| US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| AU2015270418B2 (en) | 2014-06-04 | 2020-08-06 | Ds Biopharma Limited | Pharmaceutical compositions comprising DGLA and use of same |
| US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| CA3024191C (en) * | 2016-06-01 | 2024-05-28 | Nestec S.A. | Composition for use in the prophylaxis of allergic disease |
| US10966951B2 (en) | 2017-05-19 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
| US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
| MA50490A (fr) | 2018-09-24 | 2020-09-02 | Amarin Pharmaceuticals Ie Ltd | Procédés de réduction du risque d'événements cardiovasculaires chez un sujet |
| JP2022554020A (ja) | 2019-11-12 | 2022-12-27 | アマリン ファーマシューティカルズ アイルランド リミテッド | 心房細動および／または心房粗動を患う対象における心血管イベントのリスクを低減する方法 |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
| AU2022263358A1 (en) | 2021-04-21 | 2023-11-30 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of heart failure |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1417119A (en) * | 1972-11-30 | 1975-12-10 | Thiele G H | Process for treating bones |
| GB8621816D0 (en) * | 1986-09-10 | 1986-10-15 | Efamol Ltd | Therapeutic composition |
| JPH0625057B2 (ja) * | 1987-12-14 | 1994-04-06 | 日本油脂株式会社 | 骨形成促進剤 |
| GB9112052D0 (en) * | 1991-06-05 | 1991-07-24 | Efamol Holdings | Fatty acid treatment |
-
1992
- 1992-08-21 GB GB929217780A patent/GB9217780D0/en active Pending
-
1993
- 1993-08-16 AU AU44666/93A patent/AU666747B2/en not_active Ceased
- 1993-08-16 EP EP93306444A patent/EP0585026B1/en not_active Expired - Lifetime
- 1993-08-16 DK DK93306444.6T patent/DK0585026T3/da active
- 1993-08-16 JP JP5202396A patent/JPH06157303A/ja active Pending
- 1993-08-16 ZA ZA935976A patent/ZA935976B/xx unknown
- 1993-08-16 US US08/106,989 patent/US5618558A/en not_active Expired - Fee Related
- 1993-08-16 AT AT93306444T patent/ATE159856T1/de not_active IP Right Cessation
- 1993-08-16 SG SG9605801A patent/SG80536A1/en unknown
- 1993-08-16 DE DE69315020T patent/DE69315020T2/de not_active Expired - Fee Related
- 1993-08-16 ES ES93306444T patent/ES2110060T3/es not_active Expired - Lifetime
- 1993-08-17 NZ NZ248422A patent/NZ248422A/en unknown
- 1993-08-20 CA CA002104567A patent/CA2104567A1/en not_active Abandoned
- 1993-08-20 KR KR1019930016204A patent/KR940003553A/ko not_active Ceased
- 1993-08-20 NO NO932983A patent/NO306655B1/no not_active IP Right Cessation
- 1993-08-20 RU RU93049153A patent/RU2122409C1/ru active
- 1993-08-21 CN CN93118320A patent/CN1049334C/zh not_active Expired - Fee Related
- 1993-08-21 MY MYPI93001672A patent/MY109928A/en unknown
- 1993-08-23 TW TW082106797A patent/TW323230B/zh active
-
1997
- 1997-12-29 HK HK97102670A patent/HK1000997A1/en not_active IP Right Cessation
-
1998
- 1998-01-14 GR GR980400071T patent/GR3025898T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69315020T2 (de) | 1998-04-16 |
| ATE159856T1 (de) | 1997-11-15 |
| US5618558A (en) | 1997-04-08 |
| ES2110060T3 (es) | 1998-02-01 |
| CN1091285A (zh) | 1994-08-31 |
| SG80536A1 (en) | 2001-05-22 |
| NO306655B1 (no) | 1999-12-06 |
| NZ248422A (en) | 1997-06-24 |
| CN1049334C (zh) | 2000-02-16 |
| KR940003553A (ko) | 1994-03-12 |
| GR3025898T3 (en) | 1998-04-30 |
| RU2122409C1 (ru) | 1998-11-27 |
| NO932983D0 (no) | 1993-08-20 |
| CA2104567A1 (en) | 1994-02-22 |
| EP0585026B1 (en) | 1997-11-05 |
| ZA935976B (en) | 1994-03-14 |
| JPH06157303A (ja) | 1994-06-03 |
| EP0585026A1 (en) | 1994-03-02 |
| AU666747B2 (en) | 1996-02-22 |
| AU4466693A (en) | 1994-02-24 |
| MY109928A (en) | 1997-09-30 |
| HK1000997A1 (en) | 1998-05-15 |
| TW323230B (enExample) | 1997-12-21 |
| GB9217780D0 (en) | 1992-10-07 |
| DE69315020D1 (de) | 1997-12-11 |
| NO932983L (no) | 1994-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0585026T3 (da) | Anvendelse af fedtsyrer til forøgelse af calciumabsorption fra tarmen | |
| RU93049153A (ru) | Лечение жирными кислотами | |
| ATE96313T1 (de) | Fettsaeure-zusammensetzungen. | |
| DE69231793D1 (de) | Mikrobielle öle und ihre verwendungen | |
| DE69934627D1 (de) | Konjugierte Linolsäurezusammensetzung | |
| DE69114498D1 (de) | Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen. | |
| ES2045120T4 (es) | Metodo para preparar un medicamento para el tratamiento o la prevencion de la perdida de memoria. | |
| ATE258792T1 (de) | Diät mit hohem lipidgehalt | |
| ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
| ES2053856T3 (es) | Derivados del acido 4-quinoleino carboxilico utiles para el tratamiento de enfermedades de la piel y del muco-epitelio. | |
| DK0585027T3 (da) | Anvendelse af fedtsyrer til behandling af abnorm vævsforkalkning | |
| ATE63684T1 (de) | Deodorant. | |
| FI944656A0 (fi) | Uudet kardioprotektiivset aineet | |
| ES2049703T3 (es) | Derivados sulfurados de acidos biliares. | |
| CO4790098A1 (es) | Composicion para el tratamiento de trastornos gastrointes- tinales y metodo para su fabricacion | |
| ES2011472B3 (es) | Procedimiento para el tratamiento de soluciones acuosas producidas en la carboxilacion de compuestos olefinicos no saturados. | |
| RU93036134A (ru) | Бишофит как основа для лекарственных препаратов | |
| ITFE910011V0 (it) | Dispositivo antialgale battericida nella filtrazione - purificazione depurazione dell'acqua trattata localmente per uso alimentare - indus-triale - cosmesi - ecc. | |
| MX9203784A (es) | Composiciones para el tratamiento de osteoporosis en seres humanos. | |
| CO4761071A1 (es) | Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion |